EDESA BIOTECH, INC. Foreign Currency Exchange Rate, Translation
EDESA BIOTECH, INC. (EDSA) had Foreign Currency Exchange Rate, Translation of 142.19% as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Multiple Foreign Currency Exchange Rates
us-gaap:ForeignCurrencyExchangeRateTranslation1 · last filed 2026-08-13
- 2026-06-30: Foreign Currency Exchange Rate, Translation 142.19%.
- 2025-12-31: Foreign Currency Exchange Rate, Translation 139.33%; Foreign Currency Exchange Rate, Translation as first filed 137.10%.
- 2025-09-30: Foreign Currency Exchange Rate, Translation 139.18%.
- 2025-06-30: Foreign Currency Exchange Rate, Translation 136.54%.
| Period end | Foreign Currency Exchange Rate, Translation | Foreign Currency Exchange Rate, Translation as first filed |
|---|---|---|
| 2026-06-30 | 142.19% 10-Q · filed 2026-08-13 | |
| 2025-12-31 | 139.33% 10-Q · filed 2026-05-14 | 137.10% 10-Q · filed 2026-02-13 |
| 2025-09-30 | 139.18% 10-K · filed 2025-12-12 | |
| 2025-06-30 | 136.54% 10-Q · filed 2025-08-08 | |
| 2025-03-31 | 143.55% 10-Q · filed 2025-05-14 | |
| 2024-12-31 | 143.74% 10-Q · filed 2025-02-14 | |
| 2024-06-30 | 136.80% 10-Q · filed 2024-08-09 | |
| 2023-09-30 | 135.17% 10-K · filed 2024-12-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |